| CCRIX | WCMLX | CCRIX / WCMLX | |
| Total Expense Ratio | 1.49 | 0.99 | 151% |
| Annual Report Gross Expense Ratio | 1.50 | 1.79 | 84% |
| Fund Existence | 15 years | 6 years | - |
| Gain YTD | 9.240 | 7.195 | 128% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 100000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 3.15B | 47.6M | 6,622% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 24.89 | 13.99 | 178% |
| Returns for 3 years | 83.26 | 29.05 | 287% |
| Returns for 5 years | -1.95 | -3.59 | 54% |
| Returns for 10 years | 122.14 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| VVICX | 12.25 | -0.01 | -0.08% |
| VOYA VACS Index Series SC Portfolio | |||
| CHDVX | 13.35 | -0.02 | -0.15% |
| Cullen High Dividend Equity I | |||
| MITIX | 34.05 | -0.15 | -0.44% |
| MFS Massachusetts Investors Tr I | |||
| MWEBX | 34.87 | -0.23 | -0.66% |
| MFS Global Equity B | |||
| ESCGX | 13.87 | -0.12 | -0.86% |
| Ashmore Emerging Markets Equity ESG C | |||